# CE2013353EN.01015101.xml

| 3.12.2013 | EN | Official Journal of the European Union | CE 353/151 |
| --- | --- | --- | --- |

3.12.2013

EN

Official Journal of the European Union

CE 353/151

---

Thursday 13 September 2012Tackling multiple sclerosis in Europe

P7_TA(2012)0357

Declaration of the European Parliament of 13 September 2012 on tackling multiple sclerosis in Europe

2013/C 353 E/22

The European Parliament,

The European Parliament

| — | having regard to Rule 123 of its Rules of Procedure, |
| --- | --- |

—

having regard to Rule 123 of its Rules of Procedure,

| A. | whereas approximately 600 000 Europeans suffer from multiple sclerosis (MS), which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults; |
| --- | --- |

A.

whereas approximately 600 000 Europeans suffer from multiple sclerosis (MS), which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults;

| B. | whereas most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis; |
| --- | --- |

B.

whereas most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis;

| C. | whereas in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, and have worsened in recent months; |
| --- | --- |

C.

whereas in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, and have worsened in recent months;

| 1. | Calls on the Commission and Council to:






  — | encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS; |
| --- | --- | --- |

1.

Calls on the Commission and Council to:

—

encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS;

| — | promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS; |
| --- | --- |

—

promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS;

| 2. | Calls on the Member States to:






  — | enhance equal access to quality care, for example. by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training; |
| --- | --- | --- |

2.

Calls on the Member States to:

—

enhance equal access to quality care, for example. by using certified educational training tools (such as ‘MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training;

| — | support the European Register for MS by encouraging patient data collection at national level; |
| --- | --- |

—

support the European Register for MS by encouraging patient data collection at national level;

| 3. | Instructs its President to forward this declaration, together with the names of the signatories (1), to the Council, the Commission and the Parliaments of the Member States. |
| --- | --- |

3.

Instructs its President to forward this declaration, together with the names of the signatories (1), to the Council, the Commission and the Parliaments of the Member States.

1

---

(1)  The list of signatories is published in Annex 1 to the Minutes of 13 September 2012 (P7_PV(2012)09-13(ANN1)).

1

---